Ovarian Cancer
Ovarian cancer develops in one or both ovaries and ranks among the most serious gynaecological cancers, partly because symptoms are vague and the disease is often caught late. It accounts for a meaningful share of cancer-related deaths in women, and incidence has been rising alongside westernised diets and delayed childbearing.
Key points
- Symptoms tend to be subtle, which is why the disease frequently is not caught until it has spread further.
- Care generally opens with an operation to cut away as much of the tumour as achievable, then chemotherapy to clear what is left.
- One drug class fights the cancer by linking together strands of its DNA so the cells lose their ability to multiply.
- Ongoing bloating, pelvic heaviness, feeling full quickly or new bladder changes deserve a swift check by a gynaecologist, particularly past age fifty.
How ovarian cancer is managed
Treatment almost always begins with surgery to remove as much tumour as possible, followed by chemotherapy to eliminate remaining cells. Alkylating agents such as melphalan have a long history in ovarian cancer protocols, working by cross-linking DNA strands to stop cancer cells from dividing. Broader oncology support resources can help patients understand the range of medicines involved across different regimens.
Persistent bloating, pelvic pressure, early satiety, or unexplained changes in urinary habits warrant prompt gynaecological assessment, especially in women over 50 or those with a family history of ovarian or breast cancer.